Amyotrophic lateral sclerosis and cancer: A register-based study in Sweden

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

Volumn 14, Issue 5-6, 2013, Pages 362-368

  Fang, Fang ^a   Al Chalabi, Ammar ^b   Ronnevi, Lars Olof ^a   Turner, Martin R ^c   Wirdefeldt, Karin ^a   Kamel, Freya ^d   Ye, Weimin ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

Amyotrophic lateral sclerosis; Cancer; Melanoma; Odds ratio; Relative risk

Indexed keywords

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ANUS CANCER; ARTICLE; BRAIN CANCER; BREAST CANCER; CANCER DIAGNOSIS; CANCER REGISTRY; CANCER RISK; CASE CONTROL STUDY; COLON CANCER; COMORBIDITY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; KIDNEY CANCER; LEUKEMIA; LUNG CANCER; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MELANOMA; MOUTH CANCER; NEOPLASM; OVARY CANCER; PRIORITY JOURNAL; PROSTATE CANCER; RISK REDUCTION; SKIN CANCER; SWEDEN; THYROID CANCER; TRACHEA CANCER; UTERINE CERVIX CANCER;

AGED; AGED, 80 AND OVER; AMYOTROPHIC LATERAL SCLEROSIS; BIAS (EPIDEMIOLOGY); CASE-CONTROL STUDIES; COMORBIDITY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; ODDS RATIO; REGISTRIES; SWEDEN; TIME FACTORS;

EID: 84881359788     PISSN: 21678421     EISSN: 21679223     Source Type: Journal    
DOI: 10.3109/21678421.2013.775309     Document Type: Article

References (26)

1. Tabares-Seisdedos R, Dumont N, Baudot A, Valderas JM, Climent J, Valencia A, et al. No paradox, no progress: Inverse cancer comorbidity in people with other complex diseases. Lancet Oncol. 2011 ; 12: 604-8
2. Plun-Favreau H, Lewis PA, Hardy J, Martins LM, Wood NW. Cancer and neurodegeneration: Between the devil and the deep blue sea. PLoS Genet. 2010; 6: 1001257
3. Bajaj A, Driver JA, Schernhammer ES. P arkinson's disease and cancer risk: A systematic review and meta-analysis. Cancer Causes Control. 2010 ; 21: 697-707
4. Liu R, Gao X, Lu Y, Chen H. M eta-analysis of the relationship between Parkinson's disease and melanoma. Neurology. 2011 ; 76: 2002-9
5. Driver JA, Beiser A, Au R, Kreger BE, Splansky GL, Kurth T, et al. Inverse association between cancer and Alzheimer's disease: Results from the Framingham Heart Study. Br Med J. 2012; 344: 1442
6. Elbaz A, Peterson BJ, Bower JH, Yang P, Maraganore D M, McDonnell SK, et al. Risk of cancer after the diagnosis of Parkinson's disease: A historical cohort study. Mov Disord. 2005 ; 20: 719-25
7. Lo R Y, Tanner C M, van den Eeden S K, Albers K B, Leimpeter AD, Nelson LM. Comorbid cancer in Parkinson's disease. Mov Disord. 2010; 25: 1809-17
8. Brain L, Croft PB, Wilkinson M. M otor neuron disease as a manifestation of neoplasm (with a note on the course of classical motor neuron disease). Brain. 1965 ; 88: 479-500
9. Mitchell D M, Olczak S A. R emission of a syndrome indistinguishable from motor neuron disease after resection of bronchial carcinoma. Br Med J. 1979 ; 2: 176-7
10. Sadot E, Carluer L, Corcia P, Delozier Y, Levy C, Viader F. Breast cancer and motor neuron disease: Clinical study of seven cases. Amyotroph Lateral Scler. 2007 ; 8: 288-91
11. Chio A, Brignolio F, Meineri P, Rosso MG, Tribolo A, Schiffer D. Motor neuron disease and malignancies: Results of a population based study. J Neurol. 1988 ; 235: 374-5
12. F reedman DM, Travis LB, Gridley G, Kuncl RW. Amyotrophic lateral sclerosis mortality in 1.9 million US cancer survivors. Neuroepidemiology. 2005 ; 25: 176-80
13. Fois AF, Wotton C J, Yeates D, Turner M R, Goldacre M J. Cancer in patients with motor neuron disease, multiple sclerosis and Parkinson's disease: Record linkage studies. J Neurol Neurosurg Psychiatry. 2010 ; 81: 215-21
14. Freedman DM, Curtis RE, Daugherty SE, Goedert JJ, Kuncl RW, Tucker MA. The association between cancer and amyotrophic lateral sclerosis. Cancer Causes Control. 2013 ; 24: 55-60
15. Baade P D, Fritschi L, Freedman D M. M ortality due to amyotrophic lateral sclerosis and Parkinson's disease among melanoma patients. Neuroepidemiology. 2007 ; 28: 16-20
16. Fang F, Chen H, Wirdefeldt K, Ronnevi L O, Al-Chalabi A, Peters TL, et al. Infection of the central nervous system, sepsis and amyotrophic lateral sclerosis. PLoS One. 2011; 6: 29749
17. Richardson D B. A n incidence density sampling programme for nested case-control analyses. Occup Environ Med. 2004; 61: 59
18. Barlow L, Westergren K, Holmberg L, Talback M. The completeness of the Swedish Cancer Register: A sample survey for year 1998. Acta Oncol. 2009 ; 48: 27-33
19. Armon C. Smoking may be considered an established risk factor for sporadic ALS. Neurology. 2009 ; 73: 1693-8
20. Huncharek M, Haddock KS, Reid R, Kupelnick B. Smoking as a risk factor for prostate cancer: A meta-analysis of 24 prospective cohort studies. Am J Public Health. 2010 ; 100: 693-701
21. Secretan B, Straif K, Baan R, Grosse Y, El Ghissassi F, Bouvard V, et al. A review of human carcinogens-Part E: Tobacco, areca nut, alcohol, coal smoke, and salted fi sh. Lancet Oncol. 2009 ; 10: 1033-4
22. Gooley TA, Leisenring W, Crowley J, Storer BE. Estimation of failure probabilities in the presence of competing risks: New representations of old estimators. Stat Med. 1999 ; 18: 695-706
23. Sharp L, Vernino S. P araneoplastic neuromuscular disorders. Muscle Nerve. 2012 ; 46: 839-40
24. Forsyth PA, Dalmau J, Graus F, Cwik V, Rosenblum MK, Posner JB. Motor neuron syndromes in cancer patients. Ann Neurol. 1997 ; 41: 722-30
25. Driver JA, Kurth T, Buring JE, Gaziano JM, Logroscino G. Prospective case-control study of non-fatal cancer preceding the diagnosis of Parkinson's disease. Cancer Causes Control. 2007 ; 18: 705-11
26. Driver J A, Logroscino G, Buring J E, Gaziano J M, Kurth T. A prospective cohort study of cancer incidence following the diagnosis of Parkinson's disease. Cancer Epidemiol Biomarkers Prev. 2007 ; 16: 1260-5